"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 2 | 0 | 2 |
| 1996 | 4 | 2 | 6 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 0 | 3 |
| 1999 | 8 | 1 | 9 |
| 2000 | 8 | 2 | 10 |
| 2001 | 3 | 0 | 3 |
| 2002 | 8 | 1 | 9 |
| 2003 | 6 | 3 | 9 |
| 2004 | 13 | 0 | 13 |
| 2005 | 9 | 2 | 11 |
| 2006 | 10 | 6 | 16 |
| 2007 | 10 | 2 | 12 |
| 2008 | 12 | 1 | 13 |
| 2009 | 18 | 4 | 22 |
| 2010 | 28 | 1 | 29 |
| 2011 | 22 | 6 | 28 |
| 2012 | 18 | 2 | 20 |
| 2013 | 17 | 1 | 18 |
| 2014 | 16 | 5 | 21 |
| 2015 | 24 | 2 | 26 |
| 2016 | 20 | 2 | 22 |
| 2017 | 18 | 2 | 20 |
| 2018 | 15 | 6 | 21 |
| 2019 | 27 | 5 | 32 |
| 2020 | 23 | 5 | 28 |
| 2021 | 37 | 2 | 39 |
| 2022 | 33 | 1 | 34 |
| 2023 | 25 | 0 | 25 |
| 2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Adv. 2024 Apr 23; 8(8):1880-1892.
-
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10; 78(4):1056-1064.
-
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Netw Open. 2024 Apr 01; 7(4):e244954.
-
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network. Clin Infect Dis. 2024 03 20; 78(3):746-755.
-
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. MMWR Morb Mortal Wkly Rep. 2024 Feb 29; 73(8):168-174.
-
Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection. Front Immunol. 2024; 15:1302489.
-
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. J Infect Dis. 2024 Feb 14; 229(2):327-340.
-
Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA Pediatr. 2024 Feb 01; 178(2):176-184.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 01 25; 78(1):217-226.
-
Emerging data in COVID-19 create urgent challengers for health providers: Updates on COVID-19 vaccine and Paxlovid. J Natl Med Assoc. 2024 Apr; 116(2 Pt 1):174-179.